1 Department of Cardiovascular Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, P.R. China.
2 Department of Respiratory Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, P.R. China.
Exp Biol Med (Maywood). 2018 Jun;243(10):852-863. doi: 10.1177/1535370218777972. Epub 2018 May 27.
The voltage-gated sodium channel 1.5 (Nav1.5), encoded by the SCN5A gene, is responsible for the rising phase of the action potential of cardiomyocytes. The sodium current mediated by Nav1.5 consists of peak and late components (I and I). Mutant Nav1.5 causes alterations in the peak and late sodium current and is associated with an increasingly wide range of congenital arrhythmias. More than 400 mutations have been identified in the SCN5A gene. Although the mechanisms of SCN5A mutations leading to a variety of arrhythmias can be classified according to the alteration of I and I as gain-of-function, loss-of-function and both, few researchers have summarized the mechanisms in this way before. In this review article, we aim to review the mechanisms underlying dysfunctional Nav1.5 due to SCN5A mutations and to provide some new insights into further approaches in the treatment of arrhythmias. Impact statement The field of ion channelopathy caused by dysfunctional Nav1.5 due to SCN5A mutations is rapidly evolving as novel technologies of electrophysiology are introduced and our understanding of the mechanisms of various arrhythmias develops. In this review, we focus on the dysfunctional Nav1.5 related to arrhythmias and the underlying mechanisms. We update SCN5A mutations in a precise way since 2013 and presents novel classifications of SCN5A mutations responsible for the dysfunction of the peak (I) and late (I) sodium channels based on their phenotypes, including loss-, gain-, and coexistence of gain- and loss-of function mutations in I, I, respectively. We hope this review will provide a new comprehensive way to better understand the electrophysiological mechanisms underlying arrhythmias from cell to bedside, promoting the management of various arrhythmias in practice.
电压门控钠离子通道 1.5(Nav1.5)由 SCN5A 基因编码,负责心肌细胞动作电位的上升相。Nav1.5 介导的钠离子电流由峰电流和迟后电流(I 和 I)组成。突变的 Nav1.5 导致峰电流和迟后钠电流的改变,并与越来越广泛的先天性心律失常有关。SCN5A 基因已发现超过 400 种突变。尽管 SCN5A 突变导致各种心律失常的机制可以根据 I 和 I 的改变分为功能获得、功能丧失和两者兼有,但以前很少有研究人员以这种方式总结这些机制。在这篇综述文章中,我们旨在回顾 SCN5A 突变导致 Nav1.5 功能障碍的机制,并为心律失常的治疗提供一些新的见解。
由于 SCN5A 突变导致 Nav1.5 功能障碍引起的离子通道病领域正在迅速发展,随着电生理学新技术的引入和我们对各种心律失常机制的理解的发展。在这篇综述中,我们重点关注与心律失常相关的功能障碍 Nav1.5 及其潜在机制。我们自 2013 年以来以精确的方式更新 SCN5A 突变,并根据其表型对导致峰电流(I)和迟后电流(I)钠离子通道功能障碍的 SCN5A 突变进行新的分类,包括 I、I 中的功能丧失、功能获得和功能获得与丧失共存突变,分别。我们希望这篇综述将为更好地理解从细胞到床边的心律失常的电生理机制提供一种新的综合方法,促进各种心律失常在实践中的管理。